BioWorld MedTech

May 9, 2012

NewCo on the Block: MID secures bridge financing, prepares for first-in-man trial

The market for percutaneous catheter-based heart procedures such as transcatheter aortic valve replacement (TAVR) has been developing at a rapid pace, but vascular access and closure devices have not been able to keep up. Read More

St. Jude Medical gains FDA approval for Assura portfolio

Report from Europe: Truer Medical earns CE mark for range of medical devices

Washington roundup: Upton: White House will see FDA user fee bill by July 4

Financings roundup: Select Medical commences $365M placement of notes

Agreements/contracts: Luna Innovations, Philips to build new robotic device

HIT roundup: Telit cellular module to connect CardioNet MCOT

Restructuring roundup: HearUSA's amended plan of liquidation accepted

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 8, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 8, 2025.

House passes H.R. 1, restoring R&D tax cuts

BioWorld MedTech

The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...

Illustration of the β2-adrenergic receptor

Exercise-mimicking compound offers alternative to GLP-1 therapies

BioWorld

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...

3D rendering of a molecular glue mediating the interaction between two proteins

With surface mimicry, molecular glues shed hairpin need

BioWorld Science

Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...